Search - tctmd.com

Displaying 1 - 20 of 70

Sort: Relevancy | Date

News Conference News TCT 2016

ILLUMENATE: Low-Dose DCB Bests Angioplasty Alone in Complex Patients With SFA/Popliteal Lesions

L.A. McKeown

November 07, 2016

News Industry News TCT 2016

Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions

November 02, 2016

News Conference News TCT 2016

Debate Over Low-Risk TAVR Hinges on Definition of Patient Population and Shared Decision-Making

Yael L. Maxwell

November 02, 2016

Presentation TCT 2016

Balloon Angioplasty Vs Bare Metal Vs Stents Covered Stents: How Do You Make the Decision?

Presenter: John D. Carroll, Thomas J Forbes, Elchanan Bruckheimer

November 01, 2016

Presentation TCT 2016

Sirolimus Angioplasty Balloon for In-Stent Restenosis (SABRE) Trial: 6-Month Angiographic and 1-Year Clinical Follow Up

Presenter: Fernando Alfonso, Ran Kornowski, Pieter R. Stella

November 01, 2016

Presentation TCT 2016

TCT 92: Short and Long-term Remodeling of Pulmonary Arteries After Balloon Angioplasty in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension

Presenter: Ori Ben-Yehuda, Ehtisham Mahmud, Nicolay Danilov

October 31, 2016

Presentation TCT 2016

TCT 91: Efficacy of Aggressive Balloon Pulmonary Angioplasty on Chronic Thromboembolic Pulmonary Hypertension Beyond Normalized Mean Pulmonary Arterial Pressure

Presenter: Ori Ben-Yehuda, Ehtisham Mahmud, Yuto Shinkura

October 31, 2016

Presentation TCT 2016

TCT 90: Efficacy and Safety of Sequential Hybrid Therapy with Pulmonary Endarterectomy and Additional Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension

Presenter: Ori Ben-Yehuda, Ehtisham Mahmud, Kenichi Yanaka

October 31, 2016

Presentation TCT 2016

TCT 89: Balloon Pulmonary Angioplasty for Chronic Thromboembolic Hypertension: Report of a Two-Year Experience in a Surgical Center

Presenter: Ori Ben-Yehuda, Ehtisham Mahmud, Carlos Garcia Alonso

October 31, 2016

News Conference News TCT 2016

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

Michael O'Riordan

October 30, 2016

Presentation TCT 2016

Cath Lab Room Setup and Basic Equipment (Guiding Catheters, Wires, and Balloons)

Presenter: Bonnie H. Weiner, Jose M. Wiley

October 29, 2016

Presentation TCT 2015

Sirolimus-Eluting Angioplasty Balloon for In-Stent Restenosis (SABRE Trial): Six-Month Clinical and Angiographic Results

Presenter: Andrea Abizaid, Daniel Burkhoff, Juan F. Granada

October 14, 2015

Presentation TCT 2015

A Randomized Comparison Among Drug Eluting Balloon, Drug Eluting Stents, and Conventional Balloon Angioplasty for Lesions in the Distal Internal Pudendal Artery in Patients with Erectile Dysfunction: The Perfect-3 Study

Presenter: Andrea Abizaid, Daniel Burkhoff, Tzung-Dau Wang

October 14, 2015

News Conference News TCT 2015

Paul S. Teirstein, MD, Receives 2015 Master Operator Award

October 14, 2015

News Conference News TCT 2015

ISAR-DESIRE 4: Scoring Balloon Predilation Effective at 1 Year in Patients With DES Restenosis

October 14, 2015

News Conference News TCT 2015

IN.PACT SFA: Benefits of DCB Persist at 2 Years

October 14, 2015

Presentation TCT 2015

TCT 26: Balloon Pulmonary Angioplasty Driven by Combined Assessment of Intraarterial Anatomy and Physiology in Patients With Nonoperable Distal Chronic Thromboembolic Pulmonary Hypertension

Presenter: John P. Cheatham, Carlos Pedra, Marek Roik

October 13, 2015

Presentation TCT 2015

Clinical Trial Debate: Do DCBs Work for the BTK Indication? Yes, Perform DCB Angioplasty of BTK Lesions Correctly and They Work!

Presenter: Gary M. Ansel, J. A. Mustapha, Francesco Liistro

October 12, 2015

News Conference News TCT 2015

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

October 12, 2015

News Conference News TCT 2015

Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award

October 12, 2015

Advertisement

ILLUMENATE: Low-Dose DCB Bests Angioplasty Alone in Complex Patients With SFA/Popliteal Lesions

Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions

Debate Over Low-Risk TAVR Hinges on Definition of Patient Population and Shared Decision-Making

Balloon Angioplasty Vs Bare Metal Vs Stents Covered Stents: How Do You Make the Decision?

Sirolimus Angioplasty Balloon for In-Stent Restenosis (SABRE) Trial: 6-Month Angiographic and 1-Year Clinical Follow Up

TCT 92: Short and Long-term Remodeling of Pulmonary Arteries After Balloon Angioplasty in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension

TCT 91: Efficacy of Aggressive Balloon Pulmonary Angioplasty on Chronic Thromboembolic Pulmonary Hypertension Beyond Normalized Mean Pulmonary Arterial Pressure

TCT 90: Efficacy and Safety of Sequential Hybrid Therapy with Pulmonary Endarterectomy and Additional Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension

TCT 89: Balloon Pulmonary Angioplasty for Chronic Thromboembolic Hypertension: Report of a Two-Year Experience in a Surgical Center

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

Cath Lab Room Setup and Basic Equipment (Guiding Catheters, Wires, and Balloons)

Sirolimus-Eluting Angioplasty Balloon for In-Stent Restenosis (SABRE Trial): Six-Month Clinical and Angiographic Results

A Randomized Comparison Among Drug Eluting Balloon, Drug Eluting Stents, and Conventional Balloon Angioplasty for Lesions in the Distal Internal Pudendal Artery in Patients with Erectile Dysfunction: The Perfect-3 Study

Paul S. Teirstein, MD, Receives 2015 Master Operator Award

ISAR-DESIRE 4: Scoring Balloon Predilation Effective at 1 Year in Patients With DES Restenosis

IN.PACT SFA: Benefits of DCB Persist at 2 Years

TCT 26: Balloon Pulmonary Angioplasty Driven by Combined Assessment of Intraarterial Anatomy and Physiology in Patients With Nonoperable Distal Chronic Thromboembolic Pulmonary Hypertension

Clinical Trial Debate: Do DCBs Work for the BTK Indication? Yes, Perform DCB Angioplasty of BTK Lesions Correctly and They Work!

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content